Monetising A Vaccine Shows What It’s Really All About.

LOADSAMONEY! According to the sales pitch on Thursday from investment banks Credit Suisse and Morgan Stanley, a COVID-19 vaccine could be a “bumper revenue opportunity“, projected to earn at least $10 billion a year. Morgan Stanley’s projection is at least $10 billion a year across developed countries but Credit Suisse is bigging it up further […]

Read More…


Remdesivir – an antiviral for a specific narrow group but a wonderdrug for everyone else?

Antiviral Not Vaccine. The US Food and Drug Administration (FDA) has given full approval to remdesivir for the treatment of COVID-19.  Remdesivir has been receiving coverage since the early days of the Great Insanity – often touted as a wonderdrug – and has been in use on a compassionate patient-by-patient basis since late January as […]

Read More…



It is a virus not the virus.

Most individuals will contract a virus from at least one of the four coronavirus genera many times throughout in their lifetime, with alphacoronaviruses HCoV-229E and HCoV-NL63, and betacoronaviruses HCoV-HKU1 and HCoV-OC43 causing the common cold. Within the fours genera there are at least 23 specific known species of virus and with serotypes and probable species, […]

Read More…